Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

63.36
+0.79391.27%
Post-market: 63.360.00000.00%16:10 EDT
Volume:300
Turnover:19.01K
Market Cap:9.50M
PE:- -
High:63.36
Open:63.15
Low:63.15
Close:62.56
52wk High:64.69
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.73
T/O Rate:0.20%
Dividend:0.51
Dividend Rate:0.81%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Expands Mounjaro's Role Beyond Weight Loss to Target Cardiovascular Risk, Unlocking a New Growth Frontier in the GLP-1 Market

Stock News
·
Aug 28

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Press Release: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Dow Jones
·
Aug 28

Bernstein Issues a Buy Rating on UnitedHealth (UNH)

TIPRANKS
·
Aug 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

UnitedHealth downgraded to Hold from Buy at Erste Group

TIPRANKS
·
Aug 27

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Biotron Posts Wider Annual Loss but Boosts Asset Backing Amid Material Uncertainty

TIPRANKS
·
Aug 27